A stable aspirin-triggered lipoxin A4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils

Journal of Immunology

Volumn 173, Issue 3, 2004, Pages 2091-2098

  Ohira, Taisuke ^a,b   Bannenberg, Gerard ^a   Arita, Makoto ^a   Takahashi, Minora ^a   Ge, Qingyuan ^c   Van Dyke, Thomas E ^b   Stahl, Gregory L ^a   Serhan, Charles N ^a   Badwey, John A ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY   (United States)

^c CELL SIGNALING TECHNOLOGY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 EPI 16 (4 FLUORO)PHENOXYLIPOXIN A4 METHYL ESTER; ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ASPIRIN TRIGGERED LIPOXIN A4; CHEMOATTRACTANT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LEUKOCYTE SPECIFIC PROTEIN 1; LIPOXIN A; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; PROTEIN P55; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMOTAXIS; EPIMER; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; INFLAMMATION; MASS SPECTROMETRY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

EID: 3242797239     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.3.2091     Document Type: Article

References (53)

1. Serhan, C. N., and E. Oliw. 2001. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J. Clin. Invest. 107:1481.
2. Wallace, J. L., and S. Fiorucci. 2003. A magic bullet for mucosal protection... and aspirin is the trigger. Trends Pharmacol. Sci. 24:323.
3. Goh, J., C. Godson, H. R. Brady, and P. Macmathuna. 2003. Lipoxins: pro-resolution lipid mediators in intestinal inflammation. Gastroenterology 24:1043.
4. 4 stable analogs that block transmigration and adhesion of human PMN. Biochemistry 34:14609.
5. 4 inhibit tumor necrosis factor α-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. J. Exp. Med. 189:1923.
6. 4 and their analogs selectively downregulate PMN azurophilic degranulation. Am. J. Physiol. 276:C988.
7. 4. Nat. Med. 8:1018.
8. 4 stable analog displays a unique topical anti-inflammatory profile. J. Immunol. 169:7063.
9. Serhan, C. N., A. Jain, S. Marleau, C. Clish, A. Kantarci, B. Behbehani, S. P. Colgan, G. L. Stahl, A. Merched, N. A. Petasis, et al. 2003. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J. Immunol. 171:6856.
10. Bonnans, C., I. Vachier, C. Chavis, P. Godard, J. Bousquet, and P. Chanez. 2002. Lipoxins are potential endogenous antiimflammatory mediators in asthma. Am. J. Respir. Crit. Care Med. 165:1531.
11. 4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J. Immunol. 168:5260.
12. Fiorucci, S., E. Distrutti, O. M. de Lima, M. Romano, A. Mencarelli, M. Barbanti, E. Palazzini, A. Moreli, and J. L. Wallace. 2003. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaption to aspirin. FASEB J. 17:1171.
13. 4 receptor. Nat. Med. 8:1296.
14. 4 receptor homologue gene. J. Immunol. 169:3363.
15. 4'S anti-inflammatory actions on intestinal epithelium. Am. J. Physiol. 284:C888.
16. Maderna, P., D. C. Cottell, G. Berlasconi, N. A. Petasis, H. R. Brady, and C. Godson. 2002. Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement in rho GTPases. Am. J. Pathol. 160:2275.
17. 2+ increase in human bronchial epithelium. J. Biol. Chem. 278:10879.
18. Devchand, P. R., M. Arita, S. Hong, G. Bannenberg, R. L. Moussignac, K. Gronert, and C. N. Serhan. 2003. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. FASEB J. 17:652.
19. 4 inhibit peroxynitrite formation, NF-κB and AP-1 activation, and IL-8 gene expression in human leukocytes. Proc. Natl. Acad. Sci. USA 99:13266.
20. 4. FASEB J. 13:903.
21. Ohira, T., Q. Zhan, Q. Ge, T. E. Van Dyke, and J. A. Badwey. 2003. Protein phosphorylation in neutrophils monitored with phosphospecific antibodies. J. Immunol. Methods 281:79.
22. Ding, J., and J. A. Badwey. 1993. Stimulation of neutrophils with a chemoattractant activates several novel protein kinases that can catalyze the phosphorylation of peptides derived from p47-phox and MARCKS. J. Biol. Chem. 268:17326.
23. Lian, J. P., R.-Y. Huang, D. Robinson, and J. A. Badwey. 1999. Activation of p90-RSK and cAMP response element binding protein in stimulated neutrophils: novel effects of the pyridinyl imidazole SB 203580 on activation of the extracellular signal-regulated kinase cascade. J. Immunol. 163:4527.
24. Badwey, J. A., J. T. Curnutte, C. B. Berde, and M. L. Karnovsky. 1982. Cytochalasin E diminishes the lag phase in the release of Superoxide by human neutrophils. Biochem. Biophys. Res. Commun. 106:170.
25. Rosenfeld, J., J. Capdevielle, J. C. Guillemot, and P. Ferrara. 1992. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal. Biochem. 203:173.
26. Mann, M., R. C. Hendrickson, and A. Pandey. 2001. Analysis of proteins and proteomes by mass spectrometry. Annu. Rev. Biochem. 70:437.
27. Eng, J. K., A. L. McCormack, and J. R. Yates III. 1994. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5:976.
28. Zhao, H., N. Wakamiya, Y. Suzuki, M. T. Hamonko, and G. L. Stahl. 2002. Identification of human mannose binding lectin (MBL) recognition sites for novel inhibitory antibodies. Hybridoma Hybridomics 21:25.
29. Kennelly, P. J., and E. G. Krebs. 1991. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J. Biol. Chem. 266:5555.
30. Huang, C. K., L. Zhan, Y. Ai, and J. Jongstra. 1997. LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human PMN. J. Biol. Chem. 272:17.
31. Matsumoto, N., S. Kojima, T. Osawa, and S. Toyoshima. 1995. Protein kinase C phosphorylates p50 LSP1 and induces translocation of p50 LSP1 in T lymphocytes. J. Biochem. 117:222.
32. Carballo, E., D. Colomer, J. L. Vives-Corrons, P. J. Blackshear, and J. Gil. 1996. Characterization and purification of a protein kinase C substrate in human B cells: identification as lymphocyte-specific protein 1 (LSP1). J. Immunol. 156:1769.
33. Kyriakis, J. M., and J. Avruch. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:807.
34. Krump, E., J. S. Sanghera, S. L. Pelech, W. Furuya, and S. Grinstein. 1997. Chemotactic peptide N-formyl-met-leu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils. J. Biol. Chem. 272:937.
35. Rane, M. J., P. Y. Coxon, D. W. Powell, R. Webster, J. B. Klein, W. Pierce, P. Ping, and K. R. McLeish. 2001. p38-Kinase-dependent MAPKAP-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J. Biol. Chem. 276:3517.
36. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95.
37. Jongstra-Bilen, J., V. L. Misener, C. Wang, A. Ginzberg, A. Auerbach, A. L. Joyner, G. P. Downey, and J. Jongstra. 2000. LSP1 modulates leukocyte populations in resting and inflamed peritoneum. Blood 96:1827.
38. Wang, C., H. Hayashi, R. Harrison, B. Chiu, J. R. Chan, H. L. Ostergaard, R. D. Inman, J. Jongstra, M. I. Cybulsky, and J. Jongstra-Bilen. 2003. Modulation of Mac-1 (CD11b/CD18)-mediated adhesion by the leukocyte-specific protein 1 is key to its role in neutrophil polarization and chemotaxis. J. Immunol. 169:415.
39. Hannigan, M., L. Zhan, Y. Ai, and C.-K. Huang. 2001. Leukocyte specific gene1 protein (LSP1) is involved in chemokine KC-activated cytoskeletal reorganisation in murine neutrophils in vitro. J. Leukocyte Biol. 69:497.
40. Howard, T., Y. Li, M. Torres, A. Geurrero, and T. Coates. 1994. The 47-kD protein increased in neutrophil actin dysfunction with 47- and 89-kD protein abnormalities is lymphocyte-specific protein. Blood 83:231.
41. Zhang, Q., Y. Li, and T. H. Howard. 2000. Human lymphocyte-specific protein 1, the protein overexpressed in neutrophil actin dysfunction with 47-kDa and 89-kDa protein abnormalities (NAD 47/89), has multiple F-actin binding domains. J. Immunol. 165:2052.
42. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNutty, M. J. Blumenthal, J. R. Heys, S. W. Landvatter, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 273:739.
43. Zu, Y. L., J. Qi, A. Gilchrist, G. A. Fernandez, D. Vazquez-Abad, D. L. Kreutzer, C. K. Huang, and R. I. Sha'afi. 1998. p38-Mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-α or fMLP stimulation. J. Immunol. 160:1982.
44. Cara, D. C., J. Kaur, M. Forster, D.-M. McCaffey, and P. Kubes. 2001. Role of p38-mitogen activated protein kinase in chemokine-induced emigration and chemotaxis in vivo. J. Immunol. 167:6552.
45. Coxon, P. Y., M. J. Rane, S. Uriarte, D. W. Powell, S. Singh, W. Butt, Q. Chen, and K. R. McLeish. 2003. MAPK-activated protein kinase-2 participates in p38-MAPK-dependent and ERK-dependent functions in human neutrophils. Cell. Signal. 15:993.
46. Badger, A. M., J. N. Bradbeer, B. Votta, J. C. Lee, J. L. Adams, and D. E. Griswold. 1996. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279:1453.
47. 4 generation from human neutrophi leukocyte suspensions. Immunol. Lett. 24:237.
48. 4 analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry 39:4761.
49. Frasch, S. C., J. A. Nick, V. A. Fadok, D. L. Bratton, G. S. Worthen, and P. M. Henson. 1989. p38 Mitogen-activated protein kinase-dependent and -independent intracellular signal transduction pathways leading to apoptosis in human neutrophils. J. Biol. Chem. 273:8389.
50. 4 analogs block extracellular signal regulated kinase-dependent TNF-α secretion from human T cells. J. Immunol. 170:6266.
51. 4 with human neutrophils. J. Biol. Chem. 267:16168.
52. 4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 191:1197.
53. Bechoua, S., and L. W. Daniel. 2001. Phospholipase D is required in the signaling pathway leading to p38-MAPK activation in neutrophil-like HL-60 cells, stimulated by N-formyl-methionyl-leucyl-phenylalanine. J. Biol. Chem. 276:31752.